cloudfront
  • info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) | +1-214-736-7666 (US) | +1-740-994-0111 (US)
  • Sign In
  • Register

Report Detail



Pharma & HealthcareGlobal DNA Repair Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2541262
  • |
  • 5 November, 2018
  • |
  • Global
  • |
  • 136 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations.

Scope of the Report:

The worldwide market for DNA Repair Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the DNA Repair Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

4SC AG

ARCAGY/ GINECO GROUP

Bristol Myers Squibb

British Columbia Cancer Agency

Cambridge University Hospitals NHS Foundation Trust

Genentech

Georgetown University

German Breast Group

GlaxoSmithKline

Jiangsu Hengrui Medicine

Johnson & Johnson

Jonsson Comprehensive Cancer Center

Karyopharm Therapeutics

KuDOS Pharmaceuticals

National Health Service

National Institutes of Health

Tesaro

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

PARP Inhibitors

Other

Market Segment by Applications, can be divided into

Oncological

Stroke

There are 15 Chapters to deeply display the global DNA Repair Drugs market.

Chapter 1, to describe DNA Repair Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of DNA Repair Drugs, with sales, revenue, and price of DNA Repair Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of DNA Repair Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, DNA Repair Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe DNA Repair Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


Table of Contents

1 Market Overview

1.1 DNA Repair Drugs Introduction

1.2 Market Analysis by Type

1.2.1 PARP Inhibitors

1.2.2 Other

1.3 Market Analysis by Applications

1.3.1 Oncological

1.3.2 Stroke

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 4SC AG

2.1.1 Business Overview

2.1.2 DNA Repair Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 4SC AG DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 ARCAGY/ GINECO GROUP

2.2.1 Business Overview

2.2.2 DNA Repair Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Bristol Myers Squibb

2.3.1 Business Overview

2.3.2 DNA Repair Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 British Columbia Cancer Agency

2.4.1 Business Overview

2.4.2 DNA Repair Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Cambridge University Hospitals NHS Foundation Trust

2.5.1 Business Overview

2.5.2 DNA Repair Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Genentech

2.6.1 Business Overview

2.6.2 DNA Repair Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Genentech DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Georgetown University

2.7.1 Business Overview

2.7.2 DNA Repair Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Georgetown University DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 German Breast Group

2.8.1 Business Overview

2.8.2 DNA Repair Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 German Breast Group DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 GlaxoSmithKline

2.9.1 Business Overview

2.9.2 DNA Repair Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Jiangsu Hengrui Medicine

2.10.1 Business Overview

2.10.2 DNA Repair Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Johnson & Johnson

2.11.1 Business Overview

2.11.2 DNA Repair Drugs Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Johnson & Johnson DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Jonsson Comprehensive Cancer Center

2.12.1 Business Overview

2.12.2 DNA Repair Drugs Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Karyopharm Therapeutics

2.13.1 Business Overview

2.13.2 DNA Repair Drugs Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.14 KuDOS Pharmaceuticals

2.14.1 Business Overview

2.14.2 DNA Repair Drugs Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.15 National Health Service

2.15.1 Business Overview

2.15.2 DNA Repair Drugs Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 National Health Service DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.16 National Institutes of Health

2.16.1 Business Overview

2.16.2 DNA Repair Drugs Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 National Institutes of Health DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.17 Tesaro

2.17.1 Business Overview

2.17.2 DNA Repair Drugs Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Tesaro DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global DNA Repair Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global DNA Repair Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global DNA Repair Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 DNA Repair Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 DNA Repair Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global DNA Repair Drugs Market Analysis by Regions

4.1 Global DNA Repair Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global DNA Repair Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global DNA Repair Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America DNA Repair Drugs Sales and Growth Rate (2013-2018)

4.3 Europe DNA Repair Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific DNA Repair Drugs Sales and Growth Rate (2013-2018)

4.5 South America DNA Repair Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa DNA Repair Drugs Sales and Growth Rate (2013-2018)

5 North America DNA Repair Drugs by Countries

5.1 North America DNA Repair Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America DNA Repair Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America DNA Repair Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States DNA Repair Drugs Sales and Growth Rate (2013-2018)

5.3 Canada DNA Repair Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico DNA Repair Drugs Sales and Growth Rate (2013-2018)

6 Europe DNA Repair Drugs by Countries

6.1 Europe DNA Repair Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe DNA Repair Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe DNA Repair Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany DNA Repair Drugs Sales and Growth Rate (2013-2018)

6.3 UK DNA Repair Drugs Sales and Growth Rate (2013-2018)

6.4 France DNA Repair Drugs Sales and Growth Rate (2013-2018)

6.5 Russia DNA Repair Drugs Sales and Growth Rate (2013-2018)

6.6 Italy DNA Repair Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific DNA Repair Drugs by Countries

7.1 Asia-Pacific DNA Repair Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific DNA Repair Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific DNA Repair Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China DNA Repair Drugs Sales and Growth Rate (2013-2018)

7.3 Japan DNA Repair Drugs Sales and Growth Rate (2013-2018)

7.4 Korea DNA Repair Drugs Sales and Growth Rate (2013-2018)

7.5 India DNA Repair Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia DNA Repair Drugs Sales and Growth Rate (2013-2018)

8 South America DNA Repair Drugs by Countries

8.1 South America DNA Repair Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America DNA Repair Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America DNA Repair Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil DNA Repair Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina DNA Repair Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia DNA Repair Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa DNA Repair Drugs by Countries

9.1 Middle East and Africa DNA Repair Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa DNA Repair Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa DNA Repair Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia DNA Repair Drugs Sales and Growth Rate (2013-2018)

9.3 UAE DNA Repair Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt DNA Repair Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria DNA Repair Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa DNA Repair Drugs Sales and Growth Rate (2013-2018)

10 Global DNA Repair Drugs Market Segment by Type

10.1 Global DNA Repair Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global DNA Repair Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global DNA Repair Drugs Revenue and Market Share by Type (2013-2018)

10.2 PARP Inhibitors Sales Growth and Price

10.2.1 Global PARP Inhibitors Sales Growth (2013-2018)

10.2.2 Global PARP Inhibitors Price (2013-2018)

10.3 Other Sales Growth and Price

10.3.1 Global Other Sales Growth (2013-2018)

10.3.2 Global Other Price (2013-2018)

11 Global DNA Repair Drugs Market Segment by Application

11.1 Global DNA Repair Drugs Sales Market Share by Application (2013-2018)

11.2 Oncological Sales Growth (2013-2018)

11.3 Stroke Sales Growth (2013-2018)

12 DNA Repair Drugs Market Forecast (2018-2023)

12.1 Global DNA Repair Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 DNA Repair Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America DNA Repair Drugs Market Forecast (2018-2023)

12.2.2 Europe DNA Repair Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific DNA Repair Drugs Market Forecast (2018-2023)

12.2.4 South America DNA Repair Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa DNA Repair Drugs Market Forecast (2018-2023)

12.3 DNA Repair Drugs Market Forecast by Type (2018-2023)

12.3.1 Global DNA Repair Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global DNA Repair Drugs Market Share Forecast by Type (2018-2023)

12.4 DNA Repair Drugs Market Forecast by Application (2018-2023)

12.4.1 Global DNA Repair Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global DNA Repair Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:



Summary:
Get latest Market Research Reports on DNA Repair Drugs . Industry analysis & Market Report on DNA Repair Drugs is a syndicated market report, published as Global DNA Repair Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of DNA Repair Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,480.00
$5,220.00
$6,960.00
2,336.82
3,505.23
4,673.64
3,202.30
4,803.44
6,404.59
421,567.20
632,350.80
843,134.40
230,770.63
346,155.95
461,541.26
Add To Cart Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report